481,989 Shares in TG Therapeutics, Inc. (NASDAQ:TGTX) Purchased by Raymond James Financial Inc.
Raymond James Financial Inc. purchased a new stake in shares of TG Therapeutics, Inc. (NASDAQ:TGTX – Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The fund purchased 481,989 shares of the biopharmaceutical company’s stock, valued at approximately $14,508,000. Raymond James Financial Inc. owned about 0.31% […]
